Snoring: Clinical Trials

7 trials for Snoring, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown, 1 withdrawn. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Recruiting 1, Unknown 1, Withdrawn 1
Phase 12Completed 1, Unknown 1

Follow Snoring: new trials by email Literature Review of Snoring trials Research Report on Snoring

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.
Mouth Tape - Mild Obstructive Sleep Apnea, Snoring
Phase 2RecruitingJohns Hopkins University1002027-03-012026-06-23
Mandibular Advancement vs Home Treatment for Primary Snoring
Interventional Arm, Conservative treatment Arm - Snoring
Phase 2CompletedWashington University School of Medicine1002022-11-072025-06-06
Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing
AD036, Placebo - Sleep Disordered Breathing
Phase 2CompletedBrigham and Women's Hospital532020-12-022022-03-02
Pharmacological Intervention for Symptomatic Snoring
SAS2094AH and SAS2094BH, SAS2094AL and SAS2094BL, Placebo - Snoring
Phase 1 / Phase 2CompletedBrigham and Women's Hospital272018-12-172019-12-12
Dimethyl Fumarate for Obstructive Sleep Apnea
Dimethyl fumarate, Placebo - Obstructive Sleep Apnea, OSA
Phase 2CompletedUniversity of Michigan652015-05-012017-05-31
Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders
NT 201, a Botulinum neurotoxin type A, free of complexing proteins - Sleep-Disordered Breathing
Phase 2WithdrawnMerz Pharmaceuticals GmbH2010-03-012015-03-30
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
Polidocanol Sclerotherapy - Apnea, Snoring
Phase 1 / Phase 2UnknownLiaoyang Central Hospital302006-12-012006-11-22

Narrower conditions

Sleep Apnea Syndromes (4)  ·  Sleep Apnea, Obstructive (2)  ·  Apnea (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (7)  ·  Respiratory Sounds (7)  ·  Signs and Symptoms (7)  ·  Signs and Symptoms, Respiratory (7)  ·  Dyssomnias (5)  ·  Nervous System Diseases (5)  ·  Respiration Disorders (5)  ·  Respiratory Tract Diseases (5)  ·  Sleep Disorders, Intrinsic (5)  ·  Sleep Wake Disorders (5)  ·  Apnea (4)  ·  Sleep Apnea Syndromes (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Dimethyl Fumarate (1)  ·  incobotulinumtoxinA (1)

Sponsors

Brigham and Women's Hospital (2)  ·  Johns Hopkins University (1)  ·  Liaoyang Central Hospital (1)  ·  Merz Pharmaceuticals GmbH (1)  ·  University of Michigan (1)  ·  Washington University School of Medicine (1)

Countries

United States (5)  ·  Australia (1)

Top investigators

Scott A Sands, PhD (2)  ·  Bradley A Edwards, PhD (1)  ·  Jay Piccirillo, MD (1)  ·  Jonathan Jun, MD (1)  ·  Tiffany J. Braley, MD, MS (1)

Results publications

PMID 29800466, PMID 38780959, PMID 39688178, PMID 40471069